Follow
Mohamad Mahdi Sleiman
Title
Cited by
Cited by
Year
Targeting the complement alternative pathway permits graft versus leukemia activity while preventing graft versus host disease
H Nguyen, A Alawieh, D Bastian, S Kuril, M Dai, A Daenthanasanmak, ...
Clinical Cancer Research 26 (13), 3481-3490, 2020
72020
In-situ pre-treatment of vascularized composite allografts with a targeted complement inhibitor protects against brain death and ischemia reperfusion induced injuries
B Lei, MM Sleiman, Q Cheng, Z Tu, P Zhu, M Goddard, PN Martins, ...
Frontiers in Immunology 12, 2583, 2021
42021
Increasing the efficacy and safety of a human complement inhibitor for treating post-transplant cardiac ischemia reperfusion injury by targeting to a graft-specific neoepitope
C Zheng, MM Sleiman, X Yang, S He, C Atkinson, S Tomlinson
The Journal of Heart and Lung Transplantation 40 (10), 1112-1121, 2021
32021
The system can't perform the operation now. Try again later.
Articles 1–3